Membership Matters

If you are a provider who has been participating in Medi-Cal Rx and have been getting Reject Codes 88 and 76, please read the Guidance Document . [Log In To Read The Memo]

Magellan Health Services, the pharmacy benefits administrator for Medi-Cal Rx, has sent the following message out to all Medi-Cal pharmacy providers. [Log In To Read The Memo]

Historically, the House of Delegates has been scheduled over a two-day weekend (i.e. Saturday – Sunday) in which the Reference Committee Report was presented the Saturday evening prior to the closing session on Sunday morning. [Log In To Read The Memo]

CPhA is proud to announce the launch of a new Medi-Cal Rx Resources page on CPhA.com in preparation for the official launch of Medi-Cal’s transition of the pharmacy benefit from Managed Care to Fee-For-Service, known as Medi-Cal Rx. [Log In To Read The Memo]

Medi-Cal is now processing claims for COVID-19 booster doses for Pfizer, Moderna and Janssen vaccines as well as pediatric (ages 5-11) doses. [Log In To Read The Memo]

CPhA is hosting a webinar with Magellan Rx, the claims administrator for the Department of Health Care Services (DHCS) Medi-Cal Rx transition. This webinar is scheduled for Wednesday, November 3 at 6:00 PM via Zoom. [Log In To Read the Memo]

There have been a number of CPhA members inquiring about the new law on electronic prescribing (e-prescribing) that is set to take effect on January 1, 2022. [Log In To Read The Memo]

The Western States Scientific Safety Review Workgroup today completed its review of the federal process and has recommended a booster dose of the Pfizer-BioNTech vaccine at least six months after their primary vaccination series for people older than 65 and people at higher risk for severe illness from COVID-19. [Log In To Read The Memo]

On Tuesday, September 14, the Department of Health and Human Services is expected to announce that pharmacists may order & administer, and pharmacy technicians and pharmacy interns may administer COVID-19 therapeutics subcutaneously, intramuscularly, or orally as authorized, approved, or licensed by the FDA. [Log In To Read The Newsletter]

As part of the Biden-Harris Administration’s ongoing commitment to increasing access to vaccinations and improving health equity, the Centers for Medicare & Medicaid Services (CMS) is expanding opportunities for people to receive COVID-19 vaccinations in their home. [Log In To Read The Memo]